-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jwa/rucuegU1Prq9y6sM/ZBOHsfymjDbNfGZc892w9k1B0EF8HiiamIrM9wQeieo AFJZNfk/n6rwXzYWToiQWg== 0000950115-96-000404.txt : 19960424 0000950115-96-000404.hdr.sgml : 19960424 ACCESSION NUMBER: 0000950115-96-000404 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960423 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PCI SERVICES INC/DE CENTRAL INDEX KEY: 0000879534 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 351724168 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-42666 FILM NUMBER: 96549784 BUSINESS ADDRESS: STREET 1: 1403 FOULK RD STE 102 CITY: WIMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024790281 MAIL ADDRESS: STREET 1: 3001 RED LION RD CITY: PHILADELPHIA STATE: PA ZIP: 19114 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MEDIQ INC CENTRAL INDEX KEY: 0000350920 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 510219413 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ONE MEDIQ PLZ CITY: PENNSAUKEN STATE: NJ ZIP: 08110 BUSINESS PHONE: 6096656300 MAIL ADDRESS: STREET 1: ONE MEDIQ PLZ CITY: PENNSAUKEN STATE: NJ ZIP: 08110 SC 13D/A 1 SCHEDULE 13-D/A ------------------------------------- OMB APPROVAL ------------------------------------- OMB Number: 3235-0145 Expires: October 31, 1997 Estimated average burden hours per response..........14.90 ------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* PCI SERVICES, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $.001 PER SHARE (Title of Class of Securities) 693206 10 4 (CUSIP Number) F. Douglas Raymond, III Drinker Biddle & Reath Philadelphia National Bank Building 1345 Chestnut Street Philadelphia, PA 19107 (215) 988-2700 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 29, 1996 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box . Check the following box if a fee is being paid with the statement , (A fee is not required only if the reporting person (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7.) Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SEC 1746 (12-91) PHTRANS:92619_3.WP5 SCHEDULE 13D - ---------------------------------------------- ---------------------------------------------- CUSIP No. 693 206 104 Page 2 of 6 Pages - ---------------------------------------------- ---------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MEDIQ Incorporated IRS Identification No. 51-0219413* - ----------------------------------------------------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) - ----------------------------------------------------------------------------------------------------------------------------- 3 SEC USE ONLY - ----------------------------------------------------------------------------------------------------------------------------- 4 SOURCE OF FUNDS* 00 - ----------------------------------------------------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) - ----------------------------------------------------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ----------------------------------------------------------------------------------------------------------------------------- NUMBER OF SHARES 7 SOLE VOTING POWER BENEFICIALLY OWNED BY EACH -0- REPORTING PERSON WITH ------------------------------------------------------------------------------------------ 8 SHARED VOTING POWER 2,875,000 ------------------------------------------------------------------------------------------ 9 SOLE DISPOSITIVE POWER -0- ------------------------------------------------------------------------------------------ 10 SHARED DISPOSITIVE POWER 2,875,000 - ----------------------------------------------------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,875,000 - ----------------------------------------------------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* - ----------------------------------------------------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 46.9% - ----------------------------------------------------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* CO - -----------------------------------------------------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 PHTRANS:92619_3.WP5 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. SCHEDULE 13D - ---------------------------------------------- ---------------------------------------------- CUSIP No. 693 206 104 Page 3 of 6 Pages - ---------------------------------------------- ---------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MEDIQ Investment Services, Inc. IRS Identification No. 51-0261761 - ----------------------------------------------------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) - ----------------------------------------------------------------------------------------------------------------------------- 3. SEC USE ONLY - ----------------------------------------------------------------------------------------------------------------------------- 4. SOURCE OF FUNDS* 00 - ----------------------------------------------------------------------------------------------------------------------------- 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) - ----------------------------------------------------------------------------------------------------------------------------- 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ----------------------------------------------------------------------------------------------------------------------------- NUMBER OF SHARES 7. SOLE VOTING POWER BENEFICIALLY OWNED BY EACH -0- REPORTING PERSON WITH ------------------------------------------------------------------------------------------ 8. SHARED VOTING POWER 2,875,000 ------------------------------------------------------------------------------------------ 9. SOLE DISPOSITIVE POWER -0- ------------------------------------------------------------------------------------------ 10. SHARED DISPOSITIVE POWER 2,875,000 - ----------------------------------------------------------------------------------------------------------------------------- 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,875,000 - ----------------------------------------------------------------------------------------------------------------------------- 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* - ----------------------------------------------------------------------------------------------------------------------------- 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 46.9% - ----------------------------------------------------------------------------------------------------------------------------- 14. TYPE OF REPORTING PERSON* CO - -----------------------------------------------------------------------------------------------------------------------------
PHTRANS:92619_3.WP5 *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. -4- PHTRANS:92619_3.WP5 The statement on Schedule 13D (the "Original Schedule 13D") dated September 9, 1992, filed with the Securities and Exchange Commission by MEDIQ Incorporated ("MEDIQ") and MEDIQ Investment Services, Inc. ("MIS", and together with MEDIQ, the "Reporting Persons") with respect to beneficial ownership of Common stock, par value $.001 per share (the "Common Stock"), of PCI Services, Inc. (the "Issuer") is hereby amended as provided herein. Item 2. Identity and Background. Item 2 is amended by adding the following: The names, business or residence addresses and present principal occupations of the directors and executive officers of the Reporting Persons are attached on Schedule I. All such persons are citizens of the United States. During the last five years, none of the Reporting Persons or such persons have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors); or have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 4. Purpose of Transaction. Item 4 is amended in its entirety and restated to read as follows: In January and February, 1996, representatives of MEDIQ met with management of the Issuer further to explore how best to accomplish MEDIQ's previously announced intention to realize the value of its investment in the Issuer by a sale of its shares of the Issuer's capital stock or other transaction, and to establish a process for realizing this value in a manner that could be shared by all of the Company's stockholders. As a result of these meetings, a representative from MEDIQ'S board of directors was invited to participate with the Issuer and the Issuer's investment bankers in exploring strategic alternatives available to the Issuer, including a possible sale of the Issuer. In addition, following these meetings and in response to a request by MEDIQ, the board of directors of the Issuer nominated for election as directors of the Issuer, for election at the 1996 annual meeting of the Issuer's stockholders, six individuals, three of whom were existing directors of the Issuer and the other three of whom, Michael J. Rotko, Sheldon M. Bonovitz and H. Scott Miller, presently are directors of MEDIQ (and in the case of Mr. Rotko, Chairman of the Board of Directors). These individuals were elected as directors of the Issuer at the Issuer's 1996 Annual Meeting, held March 29, 1996. -5- PHTRANS:92619_3.WP5 The Reporting Persons do not believe that they have formed a "group" as defined by Rule 13d-5(b)(1) to the Securities and Exchange Act of 1934 with any person, and expressly disclaim that they are members of any such group. The Reporting Persons have no immediate intentions regarding any plans or proposals which relate to or which would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, except as described herein. However, the Reporting Persons intend to review on a continuing basis their investment in the Issuer and may in the future alter their intentions. Item 5. Interest in Securities of the Issuer. Item 5 is amended by deleting paragraph (a) in its entirety and inserting in lieu thereof the following: (a) As of the date hereof, MEDIQ and MIS are the beneficial owners of 2,875,000 shares of Common Stock. Based upon the Issuer's Report on Form 10-K for the year ended September 30, 1995, 6,126,250 shares of Common Stock were outstanding on December 1, 1995. MEDIQ and MIS' Common Stock holdings represent approximately 46.9% of the shares of Common Stock outstanding. Information regarding the beneficial ownership of shares of common stock by the persons identified on Schedule 1 hereto is set forth on such schedule. -6- PHTRANS:92619_3.WP5 SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 23, 1996 MEDIQ INCORPORATED /s/ Michael F. Sandler --------------------------------- Michael F. Sandler Chief Financial Officer MEDIQ INVESTMENT SERVICES, INC. /s/ Michael F. Sandler ---------------------------------- Michael F. Sandler Chief Financial Officer -7- PHTRANS:92619_3.WP5 SCHEDULE I
Name, Business or Residence Ownership of Shares of Addresses* Principal Occupation Common Stock of the Issuer - --------------------------- -------------------- -------------------------- Michael J. Rotko, Esquire** Partner, Drinker Biddle & Reath, a -0- Philadelphia National Bank Bldg. law firm, a Director and Chairman of 1345 Chestnut Street MEDIQ and a Director of the Issuer Philadelphia, PA 19107-3496 Jacob A. Shipon** Physician, Director of MEDIQ -0- 5200 E. Roosevelt Boulevard Philadelphia, PA 19124 Thomas E. Carroll President and Chief Executive -0- Officer and a Director of MEDIQ and MIS Michael F. Sandler Vice President and Chief Financial 28,000 Officer of Issuer; Senior Vice President, Finance and Chief Financial Officer and Treasurer and a Director of MEDIQ Sheldon M. Bonovitz, Esquire Partner, Duane, Morris & 50 Duane, Morris & Heckscher Heckscher, a law firm, a Director of 4200 One Liberty Place MEDIQ and a Director of the Issuer Philadelphia, PA 19103 Lionel Felzer Retired; a Director of MEDIQ -0- Breyer Woods 412 Linden Drive Elkins Park, PA 19027 Mark S. Levitan Vice President -- Consulting -0- 529 Spring Mill Road Division, MedQuist Inc. and a Villanova, PA 19085 Director of MEDIQ H. Scott Miller President, Miller International 4,000 Pulsar Equity Partners Associates, Inc., a Director One Tower Bridge of MEDIQ and a Director of the West Conshohocken, PA 19428 Issuer
* If not otherwise indicated, the business address of each person is One Mediq Plaza, Pennsauken, NJ 08110-1460. ** Mr. Rotko, together with his mother, Bessie G. Rotko, Judith M. Shipon (the spouse of Jacob A. Shipon), John Iskrant and PNC Bank, N.A., are trustees of a Trust which owns 3,570,969 shares of the Common Stock, and 3,570,969 shares of the Preferred Stock of MEDIQ. The Trustees share voting and investment power with respect to such shares. -8- PHTRANS:92619_3.WP5 -----END PRIVACY-ENHANCED MESSAGE-----